Investment Management Team

Curt LaBelle, MD, MBAManaging Partner
Glenn RockmanPartner
Kabeer AzizSenior Associate
Charlie PettyAssociate
Dr. LaBelle has been investing in healthcare companies for over 16 years.  He has served as a Board member or observer for many successful companies, including KAI Pharmaceuticals (sold to Amgen), Sirion Therapeutics (sold to B&L and Alcon), Impulse Monitoring (sold to NuVasive), TransMolecular (sold to Morphotek), Estech (sold to Atricure), Coherex (sold to J&J), Exagen Diagnostics, SafeOp and others. Dr. LaBelle was previously a Managing Director at Tullis Health Investors and a Vice President at Investor Growth Capital.  He holds a BS in Economics from Brigham Young University, and both MD and MBA degrees from Columbia University.
Mr. Rockman started his career at J.P. Morgan, where he advised universities, research institutes, charitable foundations and other non-profit organizations on a wide variety of financing activities over more than 10 years in the firm’s investment banking division.  His time at J.P. Morgan also included three years with the firm’s Social Finance group, which has been a pioneer in the emerging field of impact investing.

After working closely with the Bill & Melinda Gates Foundation to structure and launch the Global Health Investment Fund, he left J.P. Morgan in 2014 to join the GHIF investment management team.

He received an AB from the Woodrow Wilson School of Public and International Affairs at Princeton University.

Mr. Aziz started his career at Greenhill & Co., an independent investment bank, where he advised on M&A transactions in the healthcare sector.  Prior to joining the GHIF investment management team, he was an Associate at Metalmark Capital, where he focused primarily on private equity investments in medical device companies.  Mr. Aziz graduated with honors from the Stern School of Business at New York University with a BS in Finance and Economics.
Mr. Petty joined the GHIF investment management team from Artemis Capital, where he focused on private equity investments in scientific and industrial sensors and instrumentation companies. Prior to Artemis, he lived in Haiti and worked for Sèvis Finansye Fonkoze, the country’s leading microfinance bank, where he focused on financial analysis and special projects. Prior to his time in Haiti, he was an Analyst at Fannie Mae.

Mr. Petty graduated from Virginia Tech with a BA in Political Science.

Senior Advisors

Mr. Cunningham, Founder and Principal at Innovations for Global Health (iGH), has 23 years of experience in the pharmaceutical and global health space. He has worked in the vaccine arena for the past 16 years, and led the new vaccine planning function at Merck.  He established iGH to support the assessment, acceleration, introduction and execution of global health innovations, guided by the belief that such innovations can significantly improve public health outcomes in low- and middle-income countries.  Mr. Cunningham leads iGH’s support for GHIF as a Senior Advisor to the Fund.

Mr. Cunningham spent more than three years working at the Bill & Melinda Gates Foundation (BMGF) where he supported the HIV, TB and Malaria program teams, and worked closely with a range of partners including multi-national corporations, emerging market manufacturers, WHO, UNICEF, Gavi and others to support delivery of new vaccines and the eradication of polio.

In addition, while at BMGF, he negotiated a number of partnerships to drive access to new vaccines. He was responsible for assessments of new technologies for IPV to support polio eradication as well as partner/supplier assessments including leadership of technical, financial and legal diligence efforts for multiple manufacturers.

Mr. Cunningham has an MA (Engineering) and an M. Eng. (Manuf. Engineering) degree from Cambridge University, in addition to an MBA (Marketing & International Business) from the University of Michigan.

Ms. Yanatos provides outsourced operational, regulatory, audit and tax services to GHIF.  She is a senior financial professional with extensive experience in investment analysis and valuation, fundraising, SEC and other financial reporting, accounting, audit and tax.

Headquartered in Midtown Manhattan

Address: 501 5th Avenue, New York, NY 10017


Executing upon our global health mandate from a leading financial center.